glp 1 liver enzymes Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Glucagon-like peptide (GLP)-1 and GLP-2
Description
Some patients may require slower titration if they experience persistent nausea or vomiting

PLC, Phospholipase C

alopecia (RR = 5.67

Available online: 136.Krajewski P.K., Zotowska A., Szepietowski J.C
